Home > Insider Trading > Filing (0000784199-16-000199)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
784199	Cryolife Inc	CRY	Surgical & Medical Instruments & Apparatus (3841)	592417093

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1409753	B Scott Capps	Cryolife, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144	Vp, Clinical Research	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-02-19	7,353	$10.24	91,873	No	4	A	Direct
Common Stock	Acquisiton	2016-02-19	14,582	$4.83	106,455	No	4	M	Direct
Common Stock	Disposition	2016-02-19	14,582	$10.30	91,873	No	4	S	Direct
Common Stock	Acquisiton	2016-02-19	418	$4.83	92,291	No	4	M	Direct
Common Stock	Disposition	2016-02-19	418	$10.30	91,873	No	4	S	Direct
Common Stock	Acquisiton	2016-02-19	9,564	$0.00	101,437	No	4	A	Direct
Common Stock	Disposition	2016-02-19	1,594	$10.24	99,843	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2016-02-19	20,713	$0.00	20,713	$10.24
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-19	14,582	$0.00	14,582	$4.83
Common Stock	Stock Option (Right to Buy)	Disposition	2016-02-19	418	$0.00	418	$4.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,713	2017-02-19	2022-02-19	No	4	A	Direct
14,582	2010-02-23	2016-02-23	No	4	M	Direct
418	2010-02-23	2016-02-23	No	4	M	Direct

Footnotes

Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.
Represents performance stock units granted on February 19, 2015 and earned at approximately 129.3% of target based on 2015 adjusted EBITDA. Fifty percent (50%) or 4,782 shares vested and were issued on February 19, 2016. The remaining 4,782 shares earned in connection with the February 2015 grant will vest and be issued as follows: 50% on 02/19/2017, and 50% on 02/19/2018, assuming continued employment on the relevant vesting date.
These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.
Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date.
Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 23, 2009).